RxDoctor Payments Data

Kenneth Powell, DO

Pain Medicine · Jacksonville, FLNPI 1992824007

Payments from drug & device makers

$11,809in general payments, 2019–2025

Across 391 payments — averaging $30.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$1K
  • Abbott$1K
  • AbbVie$1K
  • Amgen$871
  • Collegium Pharmaceutical, Inc.$355
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$11,809100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)43$2,722
Boston Scientific36$1,494
Abbott38$1,221
AbbVie(2 entities)62$1,097
Amgen36$871
Collegium Pharmaceutical, Inc.20$355
Stryker2$275
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$244
Novartis14$207
Si-bone, Inc.4$164
Biohaven Pharmaceuticals, Inc.7$156
Spinal Simplicity, LLC2$152
SPR Therapeutics, Inc1$145
Nalu Medical, Inc.2$140
Lundbeck LLC7$137
Teva Pharmaceuticals USA, Inc.10$133
Zavation Medical Products, LLC1$127
Nevro Corp.6$125
Vertos Medical, Inc.1$123
Painteq LLC1$121
Edwards Lifesciences1$114
Pear Therapeutics (US), Inc.1$112
Bard Peripheral Vascular, Inc.3$104
Pacira Therapeutics, Inc.4$86
Pfizer5$85
Takeda Pharmaceuticals U.S.A., Inc.7$84
Tersera Therapeutics LLC5$81
Idorsia Pharmaceuticals US Inc4$70
Redhill Biopharma Inc.5$69
Avanos Medical2$60
Bioventus LLC3$60
Globus Medical2$53
Protega Pharmaceutials Inc2$50
Radius Health, Inc.2$48
Biodelivery Sciences International, Inc.3$45
Lilly USA, LLC3$45
Scilex Pharmaceuticals Inc.2$43
Ferring Pharmaceuticals Inc.3$39
Revance Therapeutics, Inc.1$33
Johnson & Johnson1$33
Amarin Pharma, Inc.2$32
Valinor Pharma, LLC2$31
Bridgebio Pharma, Inc.1$30
Axsome Therapeutics, Inc.1$28
GRT US Holding, Inc.1$28
Forte Bio-pharma LLC2$27
Centinel Spine, LLC1$26
Otsuka America Pharmaceutical, Inc.1$25
Assertio Therapeutics, Inc.2$25
Saluda Medical Americas, Inc.1$25
GSK1$25
Vertex1$23
Orthogenrx Inc.1$22
Galderma Laboratories, L.p.1$19
Relievant Medsystems, Inc.1$18
Daiichi Sankyo Inc.1$18
Curonix LLC1$16
Baudax Bio Inc.1$16
Masimo Corporation1$13
Almatica Pharma LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,809 in reported general payments places this provider in the 80th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$705,764
Medicare patients
1,563
Services billed
25,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen2,840$117,049
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen3,161$103,329
Xtampza ErOxycodone Myristate250$100,809
RelistorMethylnaltrexone Bromide18$44,131
BelbucaBuprenorphine Hcl54$42,049
MovantikNaloxegol Oxalate63$27,154
Pregabalin827$19,996
Oxycodone Hcl925$16,989
OxycontinOxycodone Hcl42$16,574
BotoxOnabotulinumtoxina11$13,381
Lidocaine121$12,992
Morphine Sulfate ErMorphine Sulfate541$12,132
Buprenorphine50$11,181
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl76$10,518
NucyntaTapentadol Hcl13$10,448

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta$355$153,306317 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$244$44,13118 claims
Redhill Biopharma Inc.Movantik$69$27,15463 claims
AbbVieBotox, Linzess$1,097$19,48222 claims
PfizerLyrica$85$8,59811 claims
Idorsia Pharmaceuticals US IncQuviviq$70$6,93914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 596 pain medicine providers in Florida.

Other pain medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →